Article Text

Download PDFPDF
Catheter based intracoronary brachytherapy leads to increased platelet activation
  1. M Jaster1,
  2. V Fuster3,
  3. P Rosenthal2,
  4. M Pauschinger1,
  5. Q-V Tran1,
  6. D Janssen1,
  7. W Hinkelbein2,
  8. P Schwimmbeck1,
  9. H-P Schultheiss1,
  10. U Rauch1
  1. 1Department of Cardiology, University Hospital Benjamin Franklin, Free University of Berlin, Berlin, Germany
  2. 2Department of Radiooncology, University Hospital Benjamin Franklin
  3. 3The Cardiovascular Institute, Mount Sinai School of Medicine, New York, USA
  1. Correspondence to:
    Dr Ursula Rauch
    Department of Cardiology, University Hospital Benjamin Franklin, Free University of Berlin, Hindenburgdamm 30, 12200 Berlin, Germany; ursula.rauchmedizin.fu-berlin.de

Abstract

Background: Vascular brachytherapy (VBT) after percutaneous coronary intervention (PCI) is associated with a higher risk of stent thrombosis than conventional treatment.

Objective: To investigate in vivo periprocedural platelet activation with and without VBT, and to assess a possible direct effect of radiation on platelet activation.

Design: Of 50 patients with stable angina, 23 received VBT after PCI, while 27 had PCI only. The 23 patients who received VBT after PCI were pretreated for one month with aspirin and clopidogrel. Platelet activation was assessed by flow cytometry.

Results: The two patient groups did not differ in their platelet activation before the intervention. There was a significant increase in activation immediately after VBT, with 21.2% (interquartile range 13.0% to 37.6%) thrombospondin positive and 54.0% (42.3% to 63.6%) CD 63 positive platelets compared with 12.7% (9.8% to 14.9%) thrombospondin positive and 37.9% (33.2% to 45.2%) CD 63 positive platelets before the intervention (p < 0.001 and p < 0.01, respectively). Patients without VBT had no periprocedural difference in platelet activation immediately after PCI. No increase in platelet activation was found after ex vivo irradiation of blood samples obtained from healthy controls.

Conclusions: Catheter based intracoronary VBT carried out according to current standards is highly thrombogenic. The current antithrombotic treatment with aspirin and clopidogrel is not sufficient to suppress platelet activation during the procedure. From in vitro experiments, it appears that platelet activation during brachytherapy is not caused by irradiation but by the procedure of catheter based VBT.

  • vascular brachytherapy
  • stent thrombosis
  • platelet activation
  • FITC, fluorescein isothiocyanate
  • IVUS, intravascular ultrasound
  • PCI, percutaneous coronary intervention
  • TSP, thrombospondin
  • VBT, vascular brachytherapy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes